RxDoctor Payments DataLook up a doctor →

Kenneth Cusi

Endocrinology, Diabetes & Metabolism · Gainesville, FLNPI 1770690752

Payments from drug & device makers

$1,929,526in general payments, 2019–2025

Across 454 payments — averaging $4250.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$1.2M
  • Novo Nordisk AS$365K
  • Merck$83K
  • Novo Nordisk$72K
  • Boehringer Ingelheim International GmbH$44K
  • Eli Lilly$31K
  • plus $94K from 18 others
$757in research payments, 2019–2025

Across 2 payments — averaging $378.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$757

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,929,526 in reported general payments places this provider in the 95th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida

Other endocrinology, diabetes & metabolism in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →